HOTH News and Press, Hoth Therapeutics Inc. From 03/24/20

Hoth Therapeutics (NASDAQ: HOTH ) has priced its public offering of 1,449,275 common shares at $3.45 per share, for expected gross proceeds of ~$5M. More news on: AIkido Pharma Inc., Hoth Therapeutics, Inc., Healthcare stocks news, , Stocks on the move, Read more ...

Milestone Pharmaceuticals (NASDAQ: MIST )  -74%  on failed etripamil study. More news on: Milestone Pharmaceuticals Inc., Invesco Mortgage Capital Inc., Baudax Bio, Inc., Stocks on the move, , Read more ...

NEW YORK , March 24, 2020 /PRNewswire/ --Hoth Therapeutics, Inc. (Nasdaq: HOTH) ("Hoth" or the "Company"), a biopharmaceutical company, today announced the pricing of its previously announced "best efforts" underwritten public offering of 1,449,275 shares of its common stock at a pri...

March 24, 2020 Palm Beach, FL –March 24, 2020 – Oncolytic viruses are becoming a new class of cancer immunotherapy weapons to combat cancer. These naturally occurring or modified viruses are a potent new weapon against cancer, according to recent reports on this growing ...

NEW YORK , March 23, 2020 /PRNewswire/ -- Hoth Therapeutics Inc. (Nasdaq: HOTH) ("Hoth" or the "Company"), a biopharmaceutical company, today announced that it intends to offer shares of its common stock in a "best efforts"  underwritten public offering. The offering is subject ...

Gainers: Jiayin Group (NASDAQ: JFIN ) +182% . More news on: Jiayin Group Inc., Hoth Therapeutics, Inc., ADMA Biologics, Inc., Stocks on the move, , Read more ...

NEW YORK , March 23, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced it has reached an agreement with Voltron Therapeutics, Inc. (Voltron) to form a joint venture entity, to be named HaloVax, to commence preclinical studies fo...

Hoth Therapeutics (NASDAQ: HOTH ) has reached an agreement with Voltron Therapeutics to form a joint venture entity (to be named HaloVax) to commence preclinical studies for the development of vaccine prospects for Coronavirus (COVID-19) based upon VaxCelerate, a self-assembling vacci...

NEW YORK , March 23, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced it has reached an agreement with Voltron Therapeutics, Hoth Therapeuticsto form a joint venture entity (to be named HaloVax) to commence preclinical stu...

NEW YORK , March 19, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) (the "Company' or "Hoth"), a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from dermatological indications ranging from atopic dermatitis, psoriasis and ac...